Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy


FİDAN S. , FİDAN E. , Alandag C. , ERKUT M. , COŞAR A. M.

ARCHIVES OF IRANIAN MEDICINE, cilt.23, ss.835-841, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23 Konu: 12
  • Basım Tarihi: 2020
  • Doi Numarası: 10.34172/aim.2020.111
  • Dergi Adı: ARCHIVES OF IRANIAN MEDICINE
  • Sayfa Sayıları: ss.835-841

Özet

Background: Reactivation of the hepatitis B virus (HBV) either during or after chemotherapy may cause serious and sometimes fatal hepatitis. All patients undergoing chemotherapy should therefore be screened in terms of HBV before chemotherapy. The purpose of this research was to identify HBV screening rates in patients with solid cancer undergoing parenteral chemotherapy and to determine the outcomes of patients undergoing HBV screening.